04/12/2024
3:30 PM | Syros Pharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
3:30 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:54 PM | Haas Jason (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:57 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:58 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:59 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:01 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
04/02/2024
3:14 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
6:04 AM | Syros Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
5:49 AM | Syros Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:56 PM | Blue Owl Capital Holdings LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G | |
02/13/2024
7:22 PM | Avidity Partners Management LP (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
5:59 PM | Bain Capital Life Sciences Fund II, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/13/2024
6:02 PM | Ally Bridge MedAlpha Master Fund L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
4:08 PM | Artal International S.C.A. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/07/2024
6:09 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/08/2024
6:06 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
3:15 PM | Point72 Asset Management, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13G | |
12/26/2023
4:19 PM | Samsara BioCapital, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/26/2023
4:24 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
3:53 PM | Syros Pharmaceuticals (Filer)
| Form 424B5 | |
12/19/2023
3:59 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:24 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:12 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
3:23 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
6:05 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:23 PM | Simonian Nancy A (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:28 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
5:47 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023
3:51 PM | Chee Conley (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:52 PM | Stephens Kristin (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:52 PM | Roth David (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
3:15 PM | Samsara BioCapital, L.P. (Filed by)
Syros Pharmaceuticals (Subject)
| Form SC 13D | |
10/20/2023
3:23 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2023
7:49 AM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:46 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:47 PM | Alles Mark J (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:48 PM | Syros Pharmaceuticals (Issuer)
Young Richard A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:05 PM | Quirk Gerald E (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
5:53 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:12 PM | Roth David (Reporting)
Syros Pharmaceuticals (Subject)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad) You might have seen that Bitcoin was one of the best performing assets of 2023.
It gained 164%.
But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin.
He found something better. Click here to find out that this 8,788% cryptocurrency is. |
07/21/2023
3:36 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2023
7:27 PM | Olson Eric R (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
3:00 PM | Olson Eric R (Reporting)
Syros Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/25/2023
4:10 PM | Syros Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
5:45 AM | Syros Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2023
11:15 PM | Syros Pharmaceuticals (Filer)
| Form EFFECT | |
04/21/2023
6:00 AM | Syros Pharmaceuticals (Filer)
| Form DEF 14A | |
04/21/2023
6:03 AM | Syros Pharmaceuticals (Filer)
| Form DEFA14A | |
04/21/2023
6:06 AM | Syros Pharmaceuticals (Filer)
| Form ARS | |
04/20/2023
3:39 PM | AKKARAJU SRINIVAS (Reporting)
Syros Pharmaceuticals (Issuer)
| Form 4/A | |
04/20/2023
3:41 PM | Syros Pharmaceuticals (Issuer)
TYSON TIMOTHY (Reporting)
| Form 4/A | |
